By inhibiting the NF-κB signaling pathway, the expression of drug-resistant related proteins, such as P-glycoprotein (P-gp), can be down-regulated to increase the concentration of chemotherapy drugs in tumor cells, thereby improving the efficacy of chemotherapy drugs (192). Here, NFKB1 is linked to neoplasm.